Published in Curr Control Trials Cardiovasc Med on October 24, 2005
ACE gene polymorphism and losartan treatment in type 2 diabetic patients with nephropathy. J Am Soc Nephrol (2008) 1.12
PharmGKB summary: very important pharmacogene information for angiotensin-converting enzyme. Pharmacogenet Genomics (2010) 0.86
Identifying Common Genetic Risk Factors of Diabetic Neuropathies. Front Endocrinol (Lausanne) (2015) 0.79
Conformational changes of blood ACE in chronic uremia. PLoS One (2012) 0.77
Pharmacogenomics: a new paradigm to personalize treatments in nephrology patients. Clin Exp Immunol (2009) 0.77
Role of angiotensin converting enzyme and angiotensinogen gene polymorphisms in angiotensin converting enzyme inhibitor-mediated antiproteinuric action in type 2 diabetic nephropathy patients. World J Diabetes (2017) 0.75
Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA (1995) 45.41
Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD Investigators. N Engl J Med (1991) 16.19
An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest (1990) 10.35
Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). The CONSENSUS Trial Study Group. N Engl J Med (1987) 8.77
Problems of reporting genetic associations with complex outcomes. Lancet (2003) 8.11
Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data. Ann Intern Med (2001) 6.22
Randomisation. BMJ (1991) 4.66
Effect of ACE inhibitors on angiographic restenosis after coronary stenting (PARIS): a randomised, double-blind, placebo-controlled trial. Lancet (2001) 2.70
National patterns of use and effectiveness of angiotensin-converting enzyme inhibitors in older patients with heart failure and left ventricular systolic dysfunction. Circulation (2004) 2.46
Meta-Analysis of effectiveness or lack thereof of angiotensin-converting enzyme inhibitors for prevention of heart failure in patients with systemic hypertension. Am J Cardiol (2004) 1.42
A placebo-controlled trial of captopril in refractory chronic congestive heart failure. Captopril Multicenter Research Group. J Am Coll Cardiol (1983) 1.35
The deletion/insertion polymorphism of the angiotensin converting enzyme gene and cardiovascular-renal risk. J Hypertens (1997) 1.27
Deletion-type allele of the angiotensin-converting enzyme gene is associated with progressive ventricular dilation after anterior myocardial infarction. Captopril and Thrombolysis Study Investigators. J Am Coll Cardiol (1995) 1.20
Renin-angiotensin system gene polymorphisms influence blood pressure and the response to angiotensin converting enzyme inhibition. J Hypertens (1995) 1.01
Regression of left ventricular hypertrophy by lisinopril after renal transplantation: role of ACE gene polymorphism. Kidney Int (2000) 0.94
ACE genotype and ACE inhibitors induced renoprotection in chronic proteinuric nephropathies1. Kidney Int (2000) 0.91
What is the impact of the ACE gene insertion/deletion (I/D) polymorphism on the clinical effectiveness and adverse events of ACE inhibitors?--Protocol of a systematic review. BMC Med Genet (2004) 0.90
Randomized placebo-controlled trial of perindopril in normotensive, normoalbuminuric patients with type 1 diabetes mellitus. QJM (2001) 0.87
Pharmacogenetic analysis of the effect of angiotensin-converting enzyme inhibitor on restenosis after percutaneous transluminal coronary angioplasty. Angiology (1999) 0.85
Angiotensin-converting enzyme gene polymorphism determines the antiproteinuric and systemic hemodynamic effect of enalapril in patients with proteinuric renal disease. Austrian Study Group of the Effects of Enalapril Treatment in Proteinuric Renal Disease. Kidney Blood Press Res (1998) 0.83
Angiotensin-converting enzyme gene I/D polymorphism and renal disease. J Mol Med (Berl) (1999) 0.82
Long-term follow-up of ACE-inhibitor versus beta-blocker treatment and their effects on blood pressure and kidney function in renal transplant recipients. Transpl Int (2003) 0.81
Effect of the insertion/deletion polymorphism of the angiotensin-converting enzyme gene on response to angiotensin-converting enzyme inhibitors in patients with heart failure. J Cardiovasc Pharmacol (1998) 0.81
Impact of ACE polymorphism on renal allograft function, blood pressure, and proteinuria under ACE inhibition. Transplant Proc (2002) 0.81
Quinapril prevents restenosis after coronary stenting in patients with angiotensin-converting enzyme D allele. Circ J (2002) 0.80
ACE genotype and ACE inhibitor response in kidney disease: a perspective. Am J Kidney Dis (2002) 0.80
Pharmacoeconomic evaluation of testing for angiotensin-converting enzyme genotype before starting beta-hydroxy-beta-methylglutaryl coenzyme A reductase inhibitor therapy in men. Pharmacogenetics (2004) 0.79
Angiotensin II formation in human vasculature after chronic ACE inhibition: a prospective, randomized, placebo-controlled study. QUO VADIS Investigators. Cardiovasc Drugs Ther (2000) 0.79
Does long-term angiotensin converting enzyme inhibition affect the concentration of tissue-type plasminogen activator-plasminogen activator inhibitor-1 in the blood of patients with a previous myocardial infarction. Coron Artery Dis (1997) 0.78
Genotype-dependent increase in plasma ACE activity after CABG is prevented by ACE inhibition. Can J Cardiol (2003) 0.77
Angiotensin-converting enzyme inhibitor therapy. S Afr Med J (1992) 0.77
Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: a prospective cohort study. J Am Soc Nephrol (2004) 7.79
Preventing microalbuminuria in type 2 diabetes. N Engl J Med (2004) 6.41
Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts. Kidney Int (2011) 5.25
Long-term outcome of renal transplantation from older donors. N Engl J Med (2006) 5.10
Comparative effectiveness and safety of medications for type 2 diabetes: an update including new drugs and 2-drug combinations. Ann Intern Med (2011) 4.76
An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med (2013) 4.49
Rituximab in idiopathic membranous nephropathy. J Am Soc Nephrol (2012) 3.79
Diagnostic value of systematic biopsy methods in the investigation of prostate cancer: a systematic review. J Urol (2006) 3.53
Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): multicentre, randomised controlled trial. Lancet (2005) 3.52
Accuracy of Ottawa ankle rules to exclude fractures of the ankle and mid-foot: systematic review. BMJ (2003) 3.34
The minimal important difference in the 6-minute walk test for patients with pulmonary arterial hypertension. Am J Respir Crit Care Med (2012) 3.24
Sodium intake, ACE inhibition, and progression to ESRD. J Am Soc Nephrol (2011) 3.13
A readers' guide to the interpretation of diagnostic test properties: clinical example of sepsis. Intensive Care Med (2003) 3.06
Accuracy of electrocardiography in diagnosis of left ventricular hypertrophy in arterial hypertension: systematic review. BMJ (2007) 2.93
Communicating accuracy of tests to general practitioners: a controlled study. BMJ (2002) 2.83
Antibiotics for exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev (2012) 2.70
A randomized trial of ways to describe test accuracy: the effect on physicians' post-test probability estimates. Ann Intern Med (2005) 2.68
Phosphate may promote CKD progression and attenuate renoprotective effect of ACE inhibition. J Am Soc Nephrol (2011) 2.60
Serotype-specific changes in invasive pneumococcal disease after pneumococcal conjugate vaccine introduction: a pooled analysis of multiple surveillance sites. PLoS Med (2013) 2.54
Are there better guidelines for allocation in liver transplantation? A novel score targeting justice and utility in the model for end-stage liver disease era. Ann Surg (2011) 2.51
Role of remission clinics in the longitudinal treatment of CKD. J Am Soc Nephrol (2008) 2.48
Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev (2011) 2.38
Multidimensional analysis of learning curves in laparoscopic sigmoid resection: eight-year results. Dis Colon Rectum (2003) 2.28
How to use an article reporting a multiple treatment comparison meta-analysis. JAMA (2012) 2.28
The comprehensive complication index: a novel continuous scale to measure surgical morbidity. Ann Surg (2013) 2.27
Evaluation of guideline recommendations on oral medications for type 2 diabetes mellitus: a systematic review. Ann Intern Med (2012) 2.24
An empirical comparison of methods for meta-analysis of diagnostic accuracy showed hierarchical models are necessary. J Clin Epidemiol (2008) 2.07
Network meta-analysis-highly attractive but more methodological research is needed. BMC Med (2011) 2.02
Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev (2009) 1.98
Efficacy and adverse events of antimuscarinics for treating overactive bladder: network meta-analyses. Eur Urol (2012) 1.96
Retarding progression of chronic renal disease: the neglected issue of residual proteinuria. Kidney Int (2003) 1.91
Validity of Charlson Comorbidity Index in patients hospitalised with acute coronary syndrome. Insights from the nationwide AMIS Plus registry 2002-2012. Heart (2013) 1.83
Rituximab in idiopathic membranous nephropathy: a one-year prospective study. J Am Soc Nephrol (2003) 1.81
Comparison of dynamic contour tonometry with goldmann applanation tonometry. Invest Ophthalmol Vis Sci (2004) 1.78
Measurable urinary albumin predicts cardiovascular risk among normoalbuminuric patients with type 2 diabetes. J Am Soc Nephrol (2012) 1.75
Impact of blood pressure control and angiotensin-converting enzyme inhibitor therapy on new-onset microalbuminuria in type 2 diabetes: a post hoc analysis of the BENEDICT trial. J Am Soc Nephrol (2006) 1.74
Prediction of first coronary events with the Framingham score: a systematic review. Am Heart J (2007) 1.74
Influence of catastrophizing on treatment outcome in patients with nonspecific low back pain: a systematic review. Spine (Phila Pa 1976) (2014) 1.72
Validity of activity monitors in health and chronic disease: a systematic review. Int J Behav Nutr Phys Act (2012) 1.70
ACE inhibition is renoprotective among obese patients with proteinuria. J Am Soc Nephrol (2011) 1.70
The impact of complications on costs of major surgical procedures: a cost analysis of 1200 patients. Ann Surg (2011) 1.69
Clinical value of diagnostic instruments for ruling out acute coronary syndrome in patients with chest pain: a systematic review. Emerg Med J (2010) 1.67
A decision aid to rule out pneumonia and reduce unnecessary prescriptions of antibiotics in primary care patients with cough and fever. BMC Med (2011) 1.66
Impact of co-morbidities on self-rated health in self-reported COPD: an analysis of NHANES 2001-2008. COPD (2013) 1.64
The accuracy of various tests for bacterial vaginosis in predicting preterm birth: a systematic review. BJOG (2004) 1.61
No association of 25-hydroxyvitamin D with exacerbations in primary care patients with COPD. Chest (2014) 1.61
Combined magnetic resonance imaging and magnetic resonance spectroscopy imaging in the diagnosis of prostate cancer: a systematic review and meta-analysis. Eur Urol (2008) 1.60
Predicting the risk of perioperative mortality in patients undergoing pancreaticoduodenectomy: a novel scoring system. Arch Surg (2011) 1.59
Heparin in pregnant women with previous placenta-mediated pregnancy complications: a prospective, randomized, multicenter, controlled clinical trial. Blood (2012) 1.58
Assessment of hepatic steatosis by expert pathologists: the end of a gold standard. Ann Surg (2009) 1.56
Radiologic criteria for the diagnosis of spinal stenosis: results of a Delphi survey. Radiology (2012) 1.55
Effects of manidipine and delapril in hypertensive patients with type 2 diabetes mellitus: the delapril and manidipine for nephroprotection in diabetes (DEMAND) randomized clinical trial. Hypertension (2011) 1.54
Diagnostic value of sonography in patients with suspected carpal tunnel syndrome: a prospective study. Arthritis Rheum (2005) 1.54
Respiratory rehabilitation after acute exacerbation of COPD may reduce risk for readmission and mortality -- a systematic review. Respir Res (2005) 1.51
Accuracy of cervicovaginal fetal fibronectin test in predicting risk of spontaneous preterm birth: systematic review. BMJ (2002) 1.51
Oral purified bacterial extracts in acute respiratory tract infections in childhood: a systematic quantitative review. Eur J Pediatr (2006) 1.50
Uncertainties in the diagnosis of lumbar spinal stenosis. Radiology (2011) 1.49
Intraocular pressure measurements using dynamic contour tonometry after laser in situ keratomileusis. Invest Ophthalmol Vis Sci (2003) 1.48
Oral purified bacterial extracts in chronic bronchitis and COPD: systematic review. Chest (2004) 1.48
The role of 11C-choline and 18F-fluorocholine positron emission tomography (PET) and PET/CT in prostate cancer: a systematic review and meta-analysis. Eur Urol (2013) 1.47
Complementary and alternative medicine in asthma: do they work? Swiss Med Wkly (2002) 1.47
Sample sizes of studies on diagnostic accuracy: literature survey. BMJ (2006) 1.44
Prevalence of plateau iris syndrome in young patients with recurrent angle closure. Clin Experiment Ophthalmol (2007) 1.43
The ADO index as a predictor of two-year mortality in general practice-based chronic obstructive pulmonary disease cohorts. Respiration (2014) 1.42
Dealing with heterogeneous populations in randomized wound trials: challenges and potential solutions. Wound Repair Regen (2012) 1.41
Renal transplantation: can we reduce calcineurin inhibitor/stop steroids? Evidence based on protocol biopsy findings. J Am Soc Nephrol (2003) 1.40
Clinical review. Comparative effectiveness of drug treatments to prevent fragility fractures: a systematic review and network meta-analysis. J Clin Endocrinol Metab (2012) 1.37
Inhaled drugs to reduce exacerbations in patients with chronic obstructive pulmonary disease: a network meta-analysis. BMC Med (2009) 1.37
Diagnostic accuracy of natriuretic peptides for heart failure. Arch Intern Med (2005) 1.37
Predicting the risk of hospital admission in older persons--validation of a brief self-administered questionnaire in three European countries. J Am Geriatr Soc (2006) 1.32
Ultrasonography in screening for developmental dysplasia of the hip in newborns: systematic review. BMJ (2005) 1.30
Support of personalized medicine through risk-stratified treatment recommendations - an environmental scan of clinical practice guidelines. BMC Med (2013) 1.27
Self-efficacy instruments for patients with chronic diseases suffer from methodological limitations--a systematic review. Health Qual Life Outcomes (2009) 1.26
Colonoscopy screening markedly reduces the occurrence of colon carcinomas and carcinoma-related death: a closed cohort study. Gastrointest Endosc (2012) 1.24
Pharmacotherapies for chronic obstructive pulmonary disease: a multiple treatment comparison meta-analysis. Clin Epidemiol (2011) 1.21
Effects of combined ACE inhibitor and angiotensin II antagonist treatment in human chronic nephropathies. Kidney Int (2003) 1.21
Efficacy of motor imagery in post-stroke rehabilitation: a systematic review. J Neuroeng Rehabil (2008) 1.20
Complex regional pain syndrome 1--the Swiss cohort study. BMC Musculoskelet Disord (2008) 1.19
Recruitment barriers in a randomized controlled trial from the physicians' perspective: a postal survey. BMC Med Res Methodol (2009) 1.19
Rituximab for idiopathic membranous nephropathy: who can benefit? Clin J Am Soc Nephrol (2006) 1.18
The comprehensive complication index: a novel and more sensitive endpoint for assessing outcome and reducing sample size in randomized controlled trials. Ann Surg (2014) 1.17
Multimorbidity and evidence generation. J Gen Intern Med (2014) 1.17
Multiple treatment comparison meta-analyses: a step forward into complexity. Clin Epidemiol (2011) 1.16
Adverse event assessment of antimuscarinics for treating overactive bladder: a network meta-analytic approach. PLoS One (2011) 1.16
Basiliximab combined with low-dose rabbit anti-human thymocyte globulin: a possible further step toward effective and minimally toxic T cell-targeted therapy in kidney transplantation. Clin J Am Soc Nephrol (2006) 1.14
Determinants of endothelial function in patients with COPD. Eur Respir J (2013) 1.13
Liver involvement in hereditary hemorrhagic telangiectasia: consensus recommendations. Liver Int (2006) 1.13
Exacerbations of chronic obstructive pulmonary disease: when are antibiotics indicated? A systematic review. Respir Res (2007) 1.12
Personalized respiratory medicine: exploring the horizon, addressing the issues. Summary of a BRN-AJRCCM workshop held in Barcelona on June 12, 2014. Am J Respir Crit Care Med (2015) 1.12